chemotherapy. Convalescence following chemotherapy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients 16 years and older Patients with a definitive diagnosis of breast, colorectal, lung, prostate, and ovarian cancers by a specialist doctor Patients who mention having nausea in their previous chemotherapy period Patients who receive chemotherapy drugs by intravenous, port, or intravenous injection along with oral intake Patients who have received at least one cycle of chemotherapy
Exclusion criteria
Exclusion criteria: Undergoing radiotherapy at the same time as chemotherapy Using other complementary treatments at the same time Having a known anxiety disorder Having problems in the skin of acupressure points (for example, edema, lesions, or skin wounds) so that effective pressure cannot be applied Having problems such as gastrointestinal diseases with nausea and vomiting, migraines, and tinnitus that are related to before the start of chemotherapy and interfere with nausea and vomiting of chemotherapy. This case will be reviewed based on the patient's statement or medical record Patients who have a minimal risk of emesis chemotherapy regimen as determined by a specialist doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea, whose score is measured by the Rhodes Nausea and Vomiting Questionnaire (statements 4, 5, and 7). Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Rhodes Nausea and Vomiting Questionnaire.;Vomiting, whose score is measured by the Rhodes Nausea and Vomiting Questionnaire (statements 1, 3, and 6). Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Rhodes Nausea and Vomiting Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety is measured by Spielberger's state-trait anxiety questionnaire. Timepoint: One hour after chemotherapy and at the end of the first to fifth days of chemotherapy. Method of measurement: The Spielberger's state-trait anxiety questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kashan University of Medical Sciences